FXAIX
Price
$222.08
Change
+$1.74 (+0.79%)
Updated
Aug 8 closing price
Net Assets
681.82B
TISPX
Price
$70.14
Change
+$0.55 (+0.79%)
Updated
Aug 8 closing price
Net Assets
N/A
Interact to see
Advertisement

FXAIX vs TISPX

Header iconFXAIX vs TISPX Comparison
Open Charts FXAIX vs TISPXBanner chart's image
Fidelity 500 Index
Price$222.08
Change+$1.74 (+0.79%)
VolumeN/A
Net Assets681.82B
Nuveen S&P 500 Index R6
Price$70.14
Change+$0.55 (+0.79%)
VolumeN/A
Net AssetsN/A
FXAIX vs TISPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FXAIX vs. TISPX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and TISPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX (1.19) and TISPX (1.15) have matching dividends . FXAIX was incepted earlier than TISPX: FXAIX (14 years) vs TISPX (23 years). TISPX (0.05) is less costly to investors than FXAIX (0.01). TISPX is a more actively managed with annual turnover of: 3.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than TISPX: FXAIX (0) vs TISPX (1000000). FXAIX (21.70) and TISPX (21.35) have marching annual gain over last year. FXAIX return over 5 years is better than : 105.40 vs. TISPX (99.68).
FXAIXTISPXFXAIX / TISPX
Total Expense Ratio0.010.0530%
Annual Report Gross Expense Ratio0.010.0530%
Fund Existence14 years23 years-
Gain YTD9.4359.440100%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets682BN/A-
Annual Yield % from dividends1.191.15103%
Returns for 1 year21.7021.35102%
Returns for 3 years62.0658.53106%
Returns for 5 years105.4099.68106%
Returns for 10 years236.50219.91108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXAI0.920.03
+2.84%
CXApp
STLD123.020.95
+0.78%
Steel Dynamics
PHIO2.25N/A
N/A
Phio Pharmaceuticals Corp
CASS41.24-0.04
-0.10%
Cass Information Systems
KYMR40.62-0.23
-0.56%
Kymera Therapeutics